急诊至ICU转运时间与住院死亡率在不同ICU收治诊断间的关联:一项事后亚组分析
该研究为荷兰回顾性队列(2009-2020年)的二次分析,纳入12家医院(4家学术医院、8家非学术教学医院)中从急诊直接收入ICU的成人患者共18,798例,中位急诊至ICU转运时间为1.9小时(四分位距1.2-3.1小时)。分析7个诊断组(每组>1500例):院外心脏骤停、非手术创伤、药物过量、脓毒症、肺炎、呼吸衰竭(排除肺炎)和颅内出血。在院外心脏骤停患者(n=3,818)中,学术医院内转运时间延长与住院死亡率升高相关(1.1-1.6小时OR 1.48,95%CI 1.08-2.02;>3.4小时OR 2.94,95%CI 1.80-4.78),而非学术教学医院中呈负相关(各五分位OR均<1.0)。非手术创伤在整体队列中>3.4小时与死亡率正相关(OR 1.90,95%CI 1.12-3.21),但按医院分层后未重现。药物过量、脓毒症、肺炎、呼吸衰竭和颅内出血中未观察到关联。
要点
- 院外心脏骤停患者中,学术医院急诊至ICU转运时间1.1-1.6小时与住院死亡率升高相关(OR 1.48,95%CI 1.08-2.02),>3.4小时OR 2.94(95%CI 1.80-4.78)。
- 院外心脏骤停患者中,非学术教学医院转运时间延长与住院死亡率呈负相关,各五分位OR均<1.0。
- 非手术创伤整体队列中,急诊至ICU转运时间>3.4小时与住院死亡率正相关(OR 1.90,95%CI 1.12-3.21),但按医院分层后未重现。
- 药物过量、脓毒症、肺炎、呼吸衰竭(排除肺炎)和颅内出血患者中,急诊至ICU转运时间与住院死亡率无关联。
- 作者认为,需在均质、风险定义明确的亚组中开展前瞻性研究,以识别可改变的延迟并定义转运时间阈值。
适用人群与场景
- 荷兰12家医院(4家学术医院、8家非学术教学医院)2009-2020年间从急诊直接收入ICU的成人患者。
- 分析7个诊断组(每组>1500例):院外心脏骤停、非手术创伤、药物过量、脓毒症、肺炎、呼吸衰竭(排除肺炎)、颅内出血。
研究设计与关键结果
- 研究类型:荷兰回顾性队列(2009-2020年)的二次分析,纳入12家医院(4家学术、8家非学术教学)共18,798例从急诊直接收入ICU的成人患者,中位急诊至ICU转运时间1.9小时(四分位距1.2-3.1小时)。
- 院外心脏骤停(n=3,818):学术医院中,急诊至ICU转运时间1.1-1.6小时与住院死亡率升高相关(OR 1.48,95%CI 1.08-2.02),>3.4小时OR 2.94(95%CI 1.80-4.78),Wald χ² P<0.001;非学术教学医院中,各五分位OR均<1.0,呈负相关(Wald χ² P<0.001)。
- 非手术创伤:整体队列中急诊至ICU转运时间>3.4小时与住院死亡率正相关(OR 1.90,95%CI 1.12-3.21;Wald χ² P=0.05),按医院分层后未重现。
- 药物过量、脓毒症、肺炎、呼吸衰竭(排除肺炎)和颅内出血:未观察到急诊至ICU转运时间与住院死亡率的关联。
证据类型、等级与局限
- 证据类型:回顾性队列研究的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,需在均质、风险定义明确的亚组中开展前瞻性研究,以识别可改变的延迟并定义转运时间阈值。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the association between emergency department (ED)-to-ICU transfer time and hospital mortality across common ICU diagnoses.
DESIGN, SETTING, AND PATIENTS: Secondary analysis of a Dutch retrospective cohort (2009-2020). Twelve hospitals (four academic and eight nonacademic teaching [NACT]) provided ED arrival and ICU admission times. Adult patients directly admitted from the ED to the ICU were included. Seven diagnostic groups (> 1500 patients each) were analyzed: out-of-hospital cardiac arrest (OHCA), nonoperative trauma, overdose, sepsis, pneumonia, respiratory failure (excluding pneumonia), and intracranial hemorrhage (ICH). Logistic regression assessed associations between ED-to-ICU time quintiles and hospital mortality, adjusting for hospital of admission, and Acute Physiology and Chronic Health Evaluation III score. Analyses were stratified by hospital type.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Among 18,798 patients, median ED-to-ICU time was 1.9 hours (interquartile range, 1.2-3.1 hr). In OHCA ( n = 3,818), associations differed by hospital type. In academic hospitals, prolonged ED-to-ICU time was associated with higher mortality (odds ratio [OR], 1.48; 95% CI, 1.08-2.02 at 1.1-1.6 hr; OR, 2.94; 95% CI, 1.80-4.78 at > 3.4 hr; Wald χ 2p < 0.001). In NACT hospitals, prolonged ED-to-ICU time was negatively associated with mortality, with ORs less than 1.0 across quintiles (Wald χ 2p < 0.001). In nonoperative trauma, a positive association between ED-to-ICU time and hospital mortality was observed in the overall cohort (OR, 1.90; 95% CI, 1.12-3.21 at > 3.4 hr; Wald χ 2p = 0.05) but was not reproduced after stratification for hospital. No associations were observed in overdose, sepsis, pneumonia, respiratory failure, or ICH.
CONCLUSIONS: The association between ED-to-ICU time and hospital mortality varied across diagnostic groups and hospital types. In OHCA, opposing associations were observed in academic and NACT hospitals. In nonoperative trauma, a positive association was observed only in the overall cohort. Prospective studies in homogeneous, risk-defined subgroups with detailed process-of-care data are needed to identify modifiable delays and define transfer-time thresholds.
参考来源
- van Herwerden MC, Groenland CNL, Termorshuizen F, et al. Association Between Emergency Department-to-ICU Transfer Time and Hospital Mortality Across ICU Admission Diagnoses: A Post Hoc Subgroup Analysis. Crit Care Med. 2026. PMID: 42312687. doi:10.1097/CCM.0000000000007207
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。